Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

114 ARTÍCULOS , VIENDO DEL 76 AL 90

Drug use in persons with and without Alzheimer's disease aged 90 years or more

Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

Age Ageing. 2016 Nov;45(6):900-904. doi: 10.1093/ageing/afw141. Epub 2016 Sep 8.

Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative

Snyder HM, Asthana S, Bain L, Brinton R, Craft S, Dubal DB, Espeland MA, Gatz M, Mielke MM, Raber J, Rapp PR, Yaffe K, Carrillo MC.

Alzheimers Dement. 2016 Nov;12(11):1186-1196. doi: 10.1016/j.jalz.2016.08.004. Epub 2016 Sep 27.

Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers

Magnin E, Démonet JF, Wallon D, Dumurgier J, Troussière AC, Jager A, Duron E, Gabelle A, de la Sayette V, Volpe-Gillot L, Tio G, Evain S, Boutoleau-Bretonnière C, Enderle A, Mouton-Liger F, Robert P, Hannequin D, Pasquier F, Hugon J, Paquet C; ePLM collaborators.

J Alzheimers Dis. 2016 Oct 18;54(4):1459-1471. doi: 10.3233/JAD-160536.

Calcium-Channel Blockers and Dementia Risk in Older Adults - National Health Insurance Service - Senior Cohort (2002-2013)

Hwang D, Kim S, Choi H, Oh IH, Kim BS, Choi HR, Kim SY, Won CW.

Circ J. 2016 Oct 25;80(11):2336-2342. doi: 10.1253/circj.CJ-16-0692. Epub 2016 Sep 21.

Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study

Tolppanen AM, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S.

BMC Geriatr. 2016 Dec 1;16(1):204. doi: 10.1186/s12877-016-0383-2.

The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up

Wallin A, Nordlund A, Jonsson M, Lind K, Edman Å, Göthlin M, Stålhammar J, Eckerström M, Kern S, Börjesson-Hanson A, Carlsson M, Olsson E, Zetterberg H, Blennow K, Svensson J, Öhrfelt A, Bjerke M, Rolstad S, Eckerström C.

J Cereb Blood Flow Metab. 2016 Jan;36(1):114-31. doi: 10.1038/jcbfm.2015.147.

What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?

Andriuta D, Moullart V, Schraen S, Devendeville A, Meyer ME, Godefroy O; Alzheimer’s Disease Neuroimaging.

J Alzheimers Dis. 2016;51(3):793-800. doi: 10.3233/JAD-150829.

Regional Hippocampal Atrophy and Higher Levels of Plasma Amyloid-Beta Are Associated With Subjective Memory Complaints in Nondemented Elderly Subjects

Cantero JL, Iglesias JE, Van Leemput K, Atienza M.

J Gerontol A Biol Sci Med Sci. 2016 Sep;71(9):1210-5. doi: 10.1093/gerona/glw022. Epub 2016 Mar 4.

Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study

Xiong C, Jasielec MS, Weng H, Fagan AM, Benzinger TL, Head D, Hassenstab J, Grant E, Sutphen CL, Buckles V, Moulder KL, Morris JC.

Neurology. 2016 Apr 19;86(16):1499-506. doi: 10.1212/WNL.0000000000002593. Epub 2016 Mar 23.

Reference measurement procedure for CSF amyloid beta (Aβ)(1-42) and the CSF Aβ(1-42) /Aβ(1-40) ratio - a cross-validation study against amyloid PET

Pannee J, Portelius E, Minthon L, Gobom J, Andreasson U, Zetterberg H, Hansson O, Blennow K.

J Neurochem. 2016 Nov;139(4):651-658. doi: 10.1111/jnc.13838. Epub 2016 Sep 30.

Genetic Association of CHAT rs3810950 and rs2177369 Polymorphisms with the Risk of Alzheimer's Disease: A Meta-Analysis

Liu Y, Chen Q, Liu X, Dou M, Li S, Zhou J, Liu H, Wu Y, Huang Z.

Biomed Res Int. 2016;2016:9418163. doi: 10.1155/2016/9418163. Epub 2016 Aug 15.

Expression of Alzheimer's disease risk genes in ischemic brain degeneration

Ułamek-Kozioł M, Pluta R, Januszewski S, Kocki J, Bogucka-Kocka A, Czuczwar SJ.

Pharmacol Rep. 2016 Dec;68(6):1345-1349. doi: 10.1016/j.pharep.2016.09.006. Epub 2016 Sep 5.

Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics

Hickman RA, Faustin A, Wisniewski T.

Neurol Clin. 2016 Nov;34(4):941-953. doi: 10.1016/j.ncl.2016.06.009. Epub 2016 Aug 4.

CLU rs9331888 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Caucasian But Not East Asian Populations

Zhang S, Li X, Ma G, Jiang Y, Liao M, Feng R, Zhang L, Liu J, Wang G, Zhao B, Jiang Q, Li K, Liu G.

Mol Neurobiol. 2016 Apr;53(3):1446-1451. doi: 10.1007/s12035-015-9098-1. Epub 2015 Jan 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias